申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US10364256B2
公开(公告)日:2019-07-30
The present invention relates to biaryl pyrazole compounds of Formula (I)
methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.
申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US20180282349A1
公开(公告)日:2018-10-04
The present invention relates to biaryl pyrazole compounds of Formula (I)
methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.
[EN] SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS<br/>[FR] COMPOSANTS À LIAISON SOUFRE POUR LE TRAITEMENT DE MALADIES ET DE TROUBLES OPHTALMIQUES
申请人:ACUCELA INC
公开号:WO2010028088A2
公开(公告)日:2010-03-11
Provided are sulphur-linked compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
申请人:Scott Ian L.
公开号:US20100093865A1
公开(公告)日:2010-04-15
Provided are sulphur-linked compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
[EN] BIARYL PYRAZOLES AS NRF2 REGULATORS<br/>[FR] BIARYL PYRAZOLES UTILISÉS COMME RÉGULATEURS DE NRF2
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2017060854A1
公开(公告)日:2017-04-13
The present invention relates to biaryl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.